Literature DB >> 10951394

Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.

A Couvelard1, F Paraf, V Gratio, J Y Scoazec, D Hénin, C Degott, J F Fléjou.   

Abstract

The purpose of this study was to determine the angiogenic profile of human oesophageal adenocarcinoma. This study was carried out on a large series of surgically resected Barrett's adenocarcinomas and associated preneoplastic lesions. Vascularization was quantified by microvessel counting and measurement of the percentage microvessel surface area after immunohistochemistry using the CD34 antibody. The expression of vascular endothelial cell growth factor (VEGF) was also examined by immunohistochemistry. Results were correlated with clinico-pathological data and prognosis. Vascularization, assessed by both microvessel counting and measurement of the microvessel surface, was statistically higher in superficial cancers than in others. Higher vascularization was correlated with a lower rate of lymph node and distant metastasis, as well as with better survival. However, when superficial carcinomas were excluded from the study, microvessel count failed to provide any significant prognostic information. Irrespective of the inclusion or exclusion of superficial tumours, the expression of VEGF was correlated with a higher vascularisation but did not provide prognostic significance. It is concluded that high angiogenic properties are acquired in precancerous lesions and early cancers in Barrett's oesophagus. Vascularization as assessed by both microvessel counting and measurement of the microvessel surface is not informative for prognosis in infiltrative Barrett's adenocarcinomas. The expression of VEGF is correlated with vascularization, but has no independent prognostic relevance. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951394     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH709>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

1.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma.

Authors:  Christian Möbius; Hubert J Stein; Ingrid Becker; Marcus Feith; Jörg Theisen; Peter Gais; Uta Jütting; J Rüdiger Siewert
Journal:  World J Surg       Date:  2004-06-04       Impact factor: 3.352

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 4.  Optical molecular imaging for detection of Barrett's-associated neoplasia.

Authors:  Nadhi Thekkek; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

Review 5.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 6.  Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.

Authors:  D J Brat; E G Van Meir
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

7.  The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Eugene Y Chang; Xin Li; Michael Jerosch-Herold; Ryan A Priest; C Kristian Enestvedt; Jingang Xu; Charles S Springer; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

Review 8.  Role of interleukin-6 in Barrett's esophagus pathogenesis.

Authors:  Katerina Dvorak; Bohuslav Dvorak
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

9.  Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.

Authors:  Rihong Zhai; Geoffrey Liu; Kofi Asomaning; Li Su; Matthew H Kulke; Rebecca S Heist; Norman S Nishioka; Thomas J Lynch; John C Wain; Xihong Lin; David C Christiani
Journal:  Carcinogenesis       Date:  2008-09-09       Impact factor: 4.944

Review 10.  Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation.

Authors:  Marina Ulla; Ernestina Gentile; Ezequiel Levy Yeyati; Maria L Diez; Demetrio Cavadas; Ricardo D Garcia-Monaco; Pablo R Ros
Journal:  World J Gastrointest Oncol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.